Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Gains from Investment Securities (2020 - 2025)

Biofrontera (BFRI) has 6 years of Gains from Investment Securities data on record, last reported at $122622.0 in Q3 2025.

  • For Q3 2025, Gains from Investment Securities fell 81.97% year-over-year to $122622.0; the TTM value through Sep 2025 reached $122622.0, down 81.25%, while the annual FY2024 figure was $1.4 million, 1265.74% up from the prior year.
  • Gains from Investment Securities reached $122622.0 in Q3 2025 per BFRI's latest filing, up from $68039.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $1.1 billion in Q2 2022 and bottomed at -$8.7 million in Q1 2022.
  • Average Gains from Investment Securities over 5 years is $56.2 million, with a median of $6000.0 recorded in 2021.
  • The widest YoY moves for Gains from Investment Securities: up 54090500.0% in 2022, down 871200.0% in 2022.
  • A 5-year view of Gains from Investment Securities shows it stood at $30737.0 in 2021, then tumbled by 5403.05% to -$1.6 million in 2022, then soared by 97.12% to -$47000.0 in 2023, then tumbled by 4965.96% to -$2.4 million in 2024, then skyrocketed by 105.15% to $122622.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $122622.0 in Q3 2025, $68039.0 in Q2 2025, and $21887.0 in Q1 2025.